Article Information
History
- May 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Carina Marquez, MD1,*,
- Andrew D. Kerkhoff, MD, PhD1,
- John Schrom, MPH1,
- Susana Rojas2,
- Douglas Black, BA1,
- Anthea Mitchell, BA3,
- Chung-Yu Wang, BA3,
- Genay Pilarowski, PhD4,
- Salustiano Ribeiro, MS5,
- Diane Jones, RN4,
- Joselin Payan4,
- Simone Manganelli, MS4,
- Susy Rojas, BS4,
- Jonathan Lemus, BA4,
- Vivek Jain, MD1,
- Gabriel Chamie, MD1,
- Valerie Tulier-Laiwa, JD2,
- Maya Petersen, MD, PhD,
- Joseph DeRisi, PhD3,** and
- Diane V. Havlir, MD1,**
- 1Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco
- 2The San Francisco Latino Task Force-Response to COVID-19, San Francisco, CA, USA
- 3Chan-Zuckerberg Biohub, San Francisco, CA
- 4Unidos en Salud, San Francisco, CA, USA
- 5Bay Area Phlebotomy and Laboratory Services, San Francisco, CA, USA
- 5Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
- ↵*Corresponding author:
Carina Marquez, MD, MPH, Associate Professor of Medicine, Division of HIV, Infectious Diseases Global Medicine, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, carina.marquez{at}ucsf.edu, Phone: 415-476-4082, Fax: 415-476-6953
↵** Authors contributed equally
Posted May 23, 2022.
COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022
